| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | SHIRE PLC | 230,636 | 54,312,000 | 2.30% | ||
| 52 | KERYX BIOPHARMACEUTICALS INCORPORATED | 3,741,656 | 57,547,000 | 2.44% | ||
| 53 | REGENERON PHARMACEUTICALS | 227,900 | 64,375,000 | 2.73% | ||
| 54 | BIOMARIN PHARMACEUTICAL INC | 1,168,504 | 72,693,000 | 3.08% | ||
| 55 | ALLERGAN PLC | 339,450 | 75,714,000 | 3.21% | ||
| 56 | National Australia Bank ADR | 1,479,982 | 76,308,000 | 3.23% | ||
| 57 | ALEXION PHARMACEUTIC | 489,108 | 76,423,000 | 3.24% | ||
| 58 | TEVA PHARMACEUTICAL INDS LTD | 1,512,587 | 79,290,000 | 3.36% | ||
| 59 | INCYTE CORP | 1,571,452 | 88,693,000 | 3.76% | ||
| 60 | VERTEX PHARMACEUTICALS INC | 1,079,464 | 102,204,000 | 4.33% | ||
| 61 | CELGENE CORP | 1,250,672 | 107,408,000 | 4.55% | ||
| 62 | GILEAD SCIENCES INC | 1,499,116 | 124,292,000 | 5.27% | ||
| 63 | AMGEN INC | 1,195,165 | 141,472,000 | 5.99% | ||
| 64 | BIOGEN INC | 561,379 | 177,008,000 | 7.50% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-14-061102, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
